As Of	Filer	Filing¹	For·On·As	Docs:Size	Issuer		Filing Agent

  2/7/24  Adage Capital Partners GP, L.L.C. SC 13G/A               1:98K  9 Meters Biopharma, Inc.          Schulte Roth & Z… LLP/FA 
  9/8/23  Nasdaq Stock Market LLC           25-NSE©                2:4K   9 Meters Biopharma, Inc.                                   
 7/21/23  Sensenig Bethany                  144                    1:5K   9 Meters Biopharma, Inc.          UBS Fin’l Svcs In… Gp/FA 
 7/19/23  Sirgo Mark A                      144                    1:13K  9 Meters Biopharma, Inc.          Fidelity Brokera… LLC/FA 
 7/18/23  9 Meters Biopharma, Inc.          8-K:1,2,3,5 7/17/23   12:227K                                   Command Financial        
 6/16/23  9 Meters Biopharma, Inc.          8-K:3       6/12/23   11:196K                                                            
 5/30/23  9 Meters Biopharma, Inc.          8-K:5,9     5/26/23   13:425K                                                            
 5/22/23  9 Meters Biopharma, Inc.          8-K:8       5/19/23   11:200K                                                            
 5/19/23  9 Meters Biopharma, Inc.          PRE 14A     5/19/23    1:1M                                                              
 5/19/23  9 Meters Biopharma, Inc.          8-K:1,2,9   5/18/23   12:260K                                                            
 5/15/23  9 Meters Biopharma, Inc.          10-Q        3/31/23   58:6.3M                                                            
 5/15/23  9 Meters Biopharma, Inc.          8-K:2,9     5/15/23   12:379K                                                            
 4/28/23  9 Meters Biopharma, Inc.          10-K/A     12/31/22   12:763K                                                            
 4/27/23  9 Meters Biopharma, Inc.          8-K:1,2,9   4/26/23   12:289K                                                            
 4/21/23  Sensenig Bethany                  144                    1:5K   9 Meters Biopharma, Inc.          UBS Fin’l Svcs In… Gp/FA 
 4/21/23  Sensenig Bethany                  4          Officer²    1:5K   9 Meters Biopharma, Inc.          9 Meters Biopharma, Inc. 
  4/6/23  9 Meters Biopharma, Inc.          8-K:1,3     3/31/23   10:162K                                                            
  4/5/23  9 Meters Biopharma, Inc.          8-K:8,9      4/5/23   12:174K                                   Command Financial        
 3/31/23  Sirgo Mark A                      4          Director²   1:5K   9 Meters Biopharma, Inc.          Wyrick Robbins Y… LLP/FA 
 3/31/23  Rice Yehuda Michael               4          Director²   1:5K   9 Meters Biopharma, Inc.          Wyrick Robbins Y… LLP/FA 

____________
¹	Filing/Form Types:  -K
	4	Statement of Changes in Beneficial Ownership of Securities by an Insider — Form 4 { The Filer is an Insider² of the Issuer }.
	8-K	Current Report — Form 8-K { Item 1: Business & Operations;  2: Financial Info;  3: Securities & Trading;  4: Accountants & Accounting;  5: Governance & Management;  6: Asset-Backed Securities;  7: Disclosures;  8: Events;  9: Financials }.
	10-K	Annual Report — Form 10-K.
	10-Q	Quarterly Report — Form 10-Q.
	25-NSE	Notice by a Securities Exchange of the Removal from Listing and Registration of Matured, Redeemed or Retired Securities — Form 25.
	144	Notice of a Proposed Sale of Securities by an Insider — Form 144 { The Filer is an Insider² of the Issuer }.
	PRE 14A	Preliminary Proxy Statement — Schedule 14A.
	SC 13G	Statement of Acquisition of Beneficial Ownership by a “Passive” Investor — Schedule 13G.
	/A	Amendment to, or Amended version of, a previous Filing of this Type.
	©	This Filing was a Confirming copy.
²	Insider:  The Filer is a Director, Officer, 10% Owner and/or Other “insider” of the Issuer.